Two Sigma Advisers’s Guardant Health GH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $124M | Buy |
2,381,800
+14,000
| +0.6% | +$729K | 0.25% | 89 |
|
2025
Q1 | $101M | Buy |
2,367,800
+52,200
| +2% | +$2.22M | 0.23% | 93 |
|
2024
Q4 | $70.7M | Buy |
2,315,600
+1,138,300
| +97% | +$34.8M | 0.16% | 125 |
|
2024
Q3 | $27M | Buy |
1,177,300
+406,500
| +53% | +$9.33M | 0.06% | 259 |
|
2024
Q2 | $22.3M | Sell |
770,800
-23,100
| -3% | -$667K | 0.05% | 308 |
|
2024
Q1 | $16.4M | Sell |
793,900
-13,400
| -2% | -$276K | 0.04% | 397 |
|
2023
Q4 | $21.8M | Sell |
807,300
-126,000
| -14% | -$3.41M | 0.05% | 309 |
|
2023
Q3 | $27.7M | Buy |
933,300
+187,100
| +25% | +$5.55M | 0.07% | 233 |
|
2023
Q2 | $26.7M | Buy |
746,200
+359,200
| +93% | +$12.9M | 0.07% | 259 |
|
2023
Q1 | $9.07M | Buy |
387,000
+210,700
| +120% | +$4.94M | 0.02% | 584 |
|
2022
Q4 | $4.8M | Buy |
176,300
+122,800
| +230% | +$3.34M | 0.01% | 798 |
|
2022
Q3 | $2.88M | Buy |
53,500
+22,800
| +74% | +$1.23M | 0.01% | 994 |
|
2022
Q2 | $1.24M | Buy |
+30,700
| New | +$1.24M | ﹤0.01% | 1475 |
|
2021
Q3 | – | Sell |
-1,700
| Closed | -$211K | – | 2517 |
|
2021
Q2 | $211K | Sell |
1,700
-24,300
| -93% | -$3.02M | ﹤0.01% | 2255 |
|
2021
Q1 | $3.97M | Buy |
+26,000
| New | +$3.97M | 0.01% | 948 |
|